The five-year-old Pacific trial on stage lll Non-small-cell cancer still reveals new findings.
In this MEDtalk the Chief Scientific Officer from Sarah Cannon research institute, David Speigel gives you the latest results from the five-year-old trial, that show a significant reduction in survival rates for patients.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
